“Costs of sales and marketing activities not subject to recovery pursuant to customer contracts, such as feasibility assessments and negotiation of contracts, are expensed as incurred and recorded as a component of Selling, general and administrative in the ac…”10-K · Feb 10, 2026 ↗
Medpace Holdings, Inc.
MEDP
Market read
No connected market move is active around Medpace Holdings, Inc..
The latest filing evidence is available. 0 of 0 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- Revenue increased 26.5% versus the comparable filing period.
- Net margin fell 3.0 percentage points.
- MEDP's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MEDP's group or a disclosed connection begins moving with it.
Research brief
The story so far
The latest filing evidence is available. 0 of 0 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- Revenue increased 26.5% versus the comparable filing period.
- Operating cash flow covered net income at 1.23x, improving versus the comparable period.
- Net margin fell 3.0 percentage points.
- MEDP's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +20.0% year over year.
- Operating cash flow covered net income at 1.58x in the latest annual period.
- Net margin changed -1.3 percentage points in the latest annual period.
- EV/sales is 254% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 28, 2026
615.73Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
Valuation discipline
Descriptive valuation snapshot
Price/sales 7.2× · EV/sales 7.0×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 30 Sept, 11:25 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for MEDP. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Latest filing assessment · baseline
Fundamentals strengthened in the latest filing
10-Q filed 2026-04-23 against the comparable filing from 2025-04-22.
What improved
- Revenue increased 26.5% versus the comparable filing period.
- Operating cash flow covered net income at 1.23x, improving versus the comparable period.
What weakened
- Net margin fell 3.0 percentage points.
Filing receipts
“Selling, General and Administrative Selling, general and administrative expenses are primarily driven by compensation and related employee benefits, as well as rent, utilities, supplies, software licenses, professional fees (e.g., legal and accounting expenses), bad debt expense, travel, marketing and other operating expenses.”
“Changes in operating assets and liabilities used $18.9 million in operating cash flows and was primarily driven by decreased accrued expenses of $23.2 million and increased prepaid expenses and other current assets of $17.6 million, partially offset by changes in other assets and liabilities, net of $11.6 million, increased accounts payable of $10.7 million and increased advanced billings of $8.1 million.”
“Changes in operating assets and liabilities used $8.7 million in operating cash flows and was primarily driven by changes in other assets and liabilities, net of $10.2 million and decreased lease liabilities of $5.3 million, partially offset by decreased accounts receivable and unbilled, net of $7.8 million and increased advanced billings of $2.0 million.”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Business ecosystem
The relationships behind MEDP
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
FTREFortrea Holdings Inc.competitorFeb 10, 2026 ▾
“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.”
ICLRICON Public Limited CompanycompetitorFeb 10, 2026 ▾
“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.”
IQVIQVIA Holdings Inc.competitorFeb 10, 2026 ▾
“Our major CRO competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MEDP is currently a Follower in the organic co-movement group Unknown Theme. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MEDP; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.